HC
GILD icon

Hourglass Capital’s Gilead Sciences GILD Stock Holding History

Hourglass Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,900
Closed -$269K – 119
2021
Q2 		$269K Hold
3,900
– – 0.06% 119
2021
Q1 		$252K Hold
3,900
– – 0.06% 117
2020
Q4 		$227K Hold
3,900
– – 0.07% 118
2020
Q3 		$246K Hold
3,900
– – 0.08% 109
2020
Q2 		$300K Hold
3,900
– – 0.11% 99
2020
Q1 		$292K Hold
3,900
– – 0.12% 91
2019
Q4 		$253K Hold
3,900
– – 0.07% 104
2019
Q3 		$247K Hold
3,900
– – 0.07% 100
2019
Q2 		$263K Hold
3,900
– – 0.07% 89
2019
Q1 		$254K Hold
3,900
– – 0.07% 91
2018
Q4 		$244K Hold
3,900
– – 0.08% 97
2018
Q3 		$301K Sell
3,900
-400
-9% -$30.2K 0.08% 95
2018
Q2 		$305K Sell
4,300
-63,475
-94% -$4.48M 0.08% 91
2018
Q1 		$5.11M Sell
67,775
-40,785
-38% -$3.24M 1.17% 38
2017
Q4 		$7.78M Sell
108,560
-1,745
-2% -$133K 1.77% 23
2017
Q3 		$8.94M Sell
110,305
-5,342
-5% -$408K 2.13% 13
2017
Q2 		$8.19M Sell
115,647
-4,000
-3% -$266K 2.05% 15
2017
Q1 		$8.13M Buy
119,647
+11,389
+11% +$801K 1.96% 16
2016
Q4 		$7.75M Sell
108,258
-161
-0.1% -$12K 1.92% 17
2016
Q3 		$8.58M Buy
108,419
+4,236
+4% +$344K 2.13% 16
2016
Q2 		$8.69M Buy
104,183
+7,900
+8% +$701K 2.15% 12
2016
Q1 		$8.85M Buy
96,283
+11,001
+13% +$992K 2.26% 12
2015
Q4 		$8.63M Buy
85,282
+22,622
+36% +$2.35M 2.24% 15
2015
Q3 		$6.15M Buy
62,660
+270
+0.4% +$30K 1.34% 32
2015
Q2 		$7.3M Sell
62,390
-2,210
-3% -$241K 1.15% 29
2015
Q1 		$6.34M Sell
64,600
-1,345
-2% -$137K 0.95% 38
2014
Q4 		$6.22M Sell
65,945
-4,795
-7% -$496K 1.12% 34
2014
Q3 		$7.53M Buy
70,740
+560
+0.8% +$54.8K 1% 28
2014
Q2 		$5.82M Buy
+70,180
New +$5.46M 0.85% 48

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hourglass Capital's GILD Position: Q3 2021 in Review

Hourglass Capital sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 3,900 shares — an estimated $269K sold.

Hourglass Capital first reported a position in GILD in Q2 2014 and held it in 29 quarters. The position peaked at $8.94M in Q3 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Hourglass Capital reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
  • Hourglass Capital sold 3,900 Gilead Sciences shares in Q3 2021, an estimated $269K.
  • Hourglass Capital first reported a position in Gilead Sciences in Q2 2014 and held it in 29 quarters.
  • Hourglass Capital's Gilead Sciences position peaked at $8.94M in Q3 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Hourglass Capital's 13F filing for Q3 2021, filed 12 Nov 2021.